Health‐related quality of life ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · atopic eczema
1 finding from 1 review
Physician‐assessed changes in clinical signs · atopic eczema
1 finding from 1 review
Patient‐reported changes in symptoms ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Investigator Global Assessment ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Health‐related quality of life ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Patient‐reported changes in symptoms · atopic eczema
Summary of findings table ‐ NB‐UVB may leads to higher patient‐reported changes in symptoms compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Investigator Global Assessment · atopic eczema
Summary of findings table ‐ NB‐UVB may leads to higher investigator Global Assessment (short‐term) compared with placebo (low certainty).
1 finding from 1 review
Health‐related quality of life ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse outcomes · atopic eczema
1 finding from 1 review
Physician‐assessed changes in clinical signs · atopic eczema
1 finding from 1 review
Patient‐reported changes in symptoms · atopic eczema
1 finding from 1 review
Investigator Global Assessment ‐ not measured · atopic eczema
The review found no eligible studies for this question.
1 finding from 1 review
Health‐related quality of life · atopic eczema
1 finding from 1 review
Participant‐rated global improvement · people with chronic plaque psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · People with palmoplantar psoriasis
1 finding from 1 review
Withdrawals due to adverse events · People with palmoplantar psoriasis
1 finding from 1 review
Clearance rate · People with palmoplantar psoriasis
NB‐UVB showed no clear difference in clearance rate compared with topical PUVA (low certainty).
1 finding from 1 review
Participant‐rated global improvement · People with chronic plaque or guttate psoriasis
1 finding from 1 review